Novo Nordisk (NVO) Stock Fights Back Against Eli Lilly with Ireland Move

TLDR Novo Nordisk plans to manufacture Wegovy weight loss pills at its Ireland facility for global markets outside the US Over 240,000 Americans started using the pill version since its January launch, with 38,220 prescriptions in week five CEO Mike Doustdar called it “one of the most successful pharmaceutical debuts ever” as company battles Eli [...]

The post Novo Nordisk (NVO) Stock Fights Back Against Eli Lilly with Ireland Move appeared first on Blockonomi.